Stress-strain index and some indicators of scleral rigidity, measured at one month after initiation of latanoprost monotherapy, could be used as biomarkers.
Called targeted mean total deviation, the metric could better detect changes in early to moderate forms of the condition through heightened sensitivity and faster rate of change over other indices.